PBM Transparency Act Advances In Senate And It’s A Far Cry From The Rebate Rule

Bill aims to lower patient costs in part by engaging the US Federal Trade Commission to shed light on pharmacy benefit manager transactions with health plans, manufacturers and pharmacies.

Bill A Small Step In The Right Direction? • Source: Shutterstock

The pharmacy benefit manager transparency legislation now pending in the Senate takes a much more incremental approach to reining in pharmacy benefit manager practices than the Trump-era Medicare rebate rule.

But it would also save taxpayers $740m over 10 years, based on a preliminary score from the Congressional Budget Office....

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet